Yield10 Bioscience, Inc. (YTEN)
USD 0.34
(0.0%)
USD 0.34
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 14.47 Million USD | 2.06% |
| 2022 | 13.9 Million USD | 12.96% |
| 2021 | 12.3 Million USD | 18.24% |
| 2020 | 10.4 Million USD | 10.7% |
| 2019 | 9.4 Million USD | -4.79% |
| 2018 | 9.87 Million USD | -3.44% |
| 2017 | 10.22 Million USD | -10.34% |
| 2016 | 11.4 Million USD | -55.58% |
| 2015 | 25.67 Million USD | -8.78% |
| 2014 | 28.14 Million USD | -14.37% |
| 2013 | 32.87 Million USD | -11.85% |
| 2012 | 37.28 Million USD | 135.38% |
| 2011 | 15.84 Million USD | 0.81% |
| 2010 | 15.71 Million USD | 0.2% |
| 2009 | 15.68 Million USD | -61.23% |
| 2008 | 40.44 Million USD | 13.94% |
| 2007 | 35.49 Million USD | 60.53% |
| 2006 | 22.11 Million USD | 478.1% |
| 2005 | 3.82 Million USD | 17.64% |
| 2004 | 3.25 Million USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 7.05 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 3.65 Million USD | 33.32% |
| 2024 Q1 | 2.74 Million USD | -13.67% |
| 2023 FY | 14.18 Million USD | 2.06% |
| 2023 Q2 | 3.66 Million USD | -5.0% |
| 2023 Q4 | 3.17 Million USD | -14.29% |
| 2023 Q1 | 3.86 Million USD | 17.29% |
| 2023 Q3 | 3.7 Million USD | 0.98% |
| 2022 Q2 | 3.53 Million USD | 1.99% |
| 2022 FY | 13.9 Million USD | 12.96% |
| 2022 Q3 | 3.6 Million USD | 1.75% |
| 2022 Q4 | 3.29 Million USD | -8.61% |
| 2022 Q1 | 3.47 Million USD | 11.22% |
| 2021 FY | 12.3 Million USD | 18.24% |
| 2021 Q2 | 3.25 Million USD | 18.45% |
| 2021 Q1 | 2.74 Million USD | -2.03% |
| 2021 Q3 | 3.18 Million USD | -2.21% |
| 2021 Q4 | 3.12 Million USD | -1.98% |
| 2020 FY | 10.4 Million USD | 10.7% |
| 2020 Q1 | 2.84 Million USD | 11.43% |
| 2020 Q2 | 2.35 Million USD | -17.18% |
| 2020 Q3 | 2.39 Million USD | 1.7% |
| 2020 Q4 | 2.8 Million USD | 16.97% |
| 2019 FY | 9.4 Million USD | -4.79% |
| 2019 Q1 | 2.4 Million USD | 19.2% |
| 2019 Q2 | 2.21 Million USD | -8.01% |
| 2019 Q3 | 2.22 Million USD | 0.27% |
| 2019 Q4 | 2.55 Million USD | 14.99% |
| 2018 FY | 9.87 Million USD | -3.44% |
| 2018 Q3 | 2.73 Million USD | 1.18% |
| 2018 Q4 | 2.02 Million USD | -26.16% |
| 2018 Q1 | 2.36 Million USD | -10.1% |
| 2018 Q2 | 2.7 Million USD | 14.28% |
| 2017 Q4 | 2.63 Million USD | 19.41% |
| 2017 FY | 10.22 Million USD | -10.34% |
| 2017 Q3 | 2.2 Million USD | -26.6% |
| 2017 Q2 | 3 Million USD | 25.95% |
| 2017 Q1 | 2.38 Million USD | 23.32% |
| 2016 FY | 11.4 Million USD | -55.58% |
| 2016 Q4 | 1.93 Million USD | -37.61% |
| 2016 Q3 | 3.1 Million USD | -47.48% |
| 2016 Q2 | 5.9 Million USD | -16.39% |
| 2016 Q1 | 7.05 Million USD | 12.78% |
| 2015 Q1 | 6.39 Million USD | -3.14% |
| 2015 Q4 | 6.25 Million USD | 0.24% |
| 2015 Q3 | 6.24 Million USD | -7.95% |
| 2015 Q2 | 6.78 Million USD | 6.13% |
| 2015 FY | 25.67 Million USD | -8.78% |
| 2014 Q4 | 6.59 Million USD | 0.58% |
| 2014 FY | 28.14 Million USD | -14.37% |
| 2014 Q1 | 8.53 Million USD | -1.86% |
| 2014 Q2 | 7.63 Million USD | -10.53% |
| 2014 Q3 | 6.56 Million USD | -14.08% |
| 2013 Q1 | 8.17 Million USD | -20.66% |
| 2013 Q2 | 8.36 Million USD | 2.4% |
| 2013 FY | 32.87 Million USD | -11.85% |
| 2013 Q3 | 7.63 Million USD | -8.71% |
| 2013 Q4 | 8.69 Million USD | 13.85% |
| 2012 Q2 | 8.44 Million USD | 91.93% |
| 2012 FY | 37.28 Million USD | 135.38% |
| 2012 Q4 | 10.29 Million USD | 27.13% |
| 2012 Q3 | 8.1 Million USD | -4.05% |
| 2012 Q1 | 4.39 Million USD | 11.0% |
| 2011 Q2 | 4.19 Million USD | 10.8% |
| 2011 Q1 | 3.78 Million USD | -1.28% |
| 2011 Q3 | 3.89 Million USD | -7.17% |
| 2011 Q4 | 3.96 Million USD | 1.75% |
| 2011 FY | 15.84 Million USD | 0.81% |
| 2010 FY | 15.71 Million USD | 0.2% |
| 2010 Q3 | 4.16 Million USD | 8.13% |
| 2010 Q1 | 3.86 Million USD | -4.77% |
| 2010 Q2 | 3.84 Million USD | -0.54% |
| 2010 Q4 | 3.83 Million USD | -7.81% |
| 2009 FY | 15.68 Million USD | -61.23% |
| 2009 Q4 | 4.06 Million USD | 2.39% |
| 2009 Q1 | 3.71 Million USD | -61.87% |
| 2009 Q2 | 3.93 Million USD | 6.03% |
| 2009 Q3 | 3.96 Million USD | 0.76% |
| 2008 Q3 | 10.61 Million USD | 5.6% |
| 2008 Q4 | 9.74 Million USD | -8.27% |
| 2008 Q2 | 10.05 Million USD | 0.25% |
| 2008 Q1 | 10.03 Million USD | 5.53% |
| 2008 FY | 40.44 Million USD | 13.94% |
| 2007 FY | 35.49 Million USD | 60.53% |
| 2007 Q3 | 9.96 Million USD | 6.24% |
| 2007 Q2 | 9.37 Million USD | 40.9% |
| 2007 Q1 | 6.65 Million USD | -23.99% |
| 2007 Q4 | 9.5 Million USD | -4.59% |
| 2006 Q1 | 1.38 Million USD | 114.1% |
| 2006 Q2 | 1.9 Million USD | 37.97% |
| 2006 Q3 | 4.87 Million USD | 155.44% |
| 2006 Q4 | 8.75 Million USD | 79.68% |
| 2006 FY | 22.11 Million USD | 478.1% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 100.0% |
| 2005 FY | 3.82 Million USD | 17.64% |
| 2005 Q4 | -9.8 Million USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | 3.25 Million USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q4 | -8.67 Million USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2003 FY | - USD | -100.0% |
| 2002 FY | 7.05 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 136.76 Million USD | 89.415% |
| Muliang Viagoo Technology, Inc. | 2.83 Million USD | -410.47% |
| N2OFF, Inc. | 7.78 Million USD | -85.935% |
| Arcadia Biosciences, Inc. | 15.96 Million USD | 9.337% |